CAS 2169919-21-3

SNDX-5613

CAS : 2169919-21-3

Revumenib (SNDX-5613) is a potent and selective oral inhibitor of menin-KMT2A interaction.Cost-effective and quality-assured.

Formule : C₃₂H₄₇FN₆O₄S

Degré de pureté : 99.12% - 99.74%

Couleur et forme : Solid

Masse moléculaire : 630.82

Ref: TM-T12943

SNDX-5613

CAS : 2169919-21-3

SNDX-5613

Degré de pureté : ≥98%

Masse moléculaire : 630.82g/mol

Ref: 54-BUP04627

Revumenib

CAS : 2169919-21-3

Formule : C₃₂H₄₇FN₆O₄S

Masse moléculaire : 630.82

Ref: 4Z-R-171001

SNDX-5613

CAS : 2169919-21-3

Revumenib, also known as SNDX-5613, is a potent and selective inhibitor of the interaction between menin and the lysine methyltransferase 2A (KMT2A). In recent studies, it has shown promising results in targeting the epigenetic regulator KMT2A, which seems to be involved in certain leukaemia subtypes.

Formule : C₃₂H₄₇FN₆O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 630.8 g/mol

Ref: 3D-ULD91921